ArticleTargeted oncology2023

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).

Hanno M Witte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.